The present study investigated the protective effect of L-citrulline on gastric mucosal injury induced by ischemia-reperfusion (IR) in rats. Under anesthesia, the celiac artery was clamped for 30 min, and then the clamp was removed for 60 min reperfusion. Sixty minutes before ischemia, L-citrulline was administered intragastrically at doses of 300, 600, and 900 mg/kg. After the experiment, the stomachs were removed for biochemical and histological examinations. Pretreatment with L-citrulline (300, 600, and 900 mg/kg) significantly ameliorated the gastric damage caused by IR. Moreover, L-citrulline prevented the production of lipid peroxidation and inhibited the increase of myeloperoxidase activity. The elevation in total nitric oxide synthase (NOS) activity, inducible NOS activity, and inducible NOS protein expression as well as the decrease in constitutive NOS activity and gastric mucus level in the gastric mucosa induced by IR were significantly prevented. However, the protective effect mediated by L-citrulline was significantly antagonized by coadministration of L-nitroarginine methyl ester (10 mg/kg, s.c.). These results suggest that part of the mechanism of gastric protection by L-citrulline might be through inhibiting neutrophil infiltration and preserving gastric mucus synthesis and secretion in rats, functions that are closely related to the maintenance of constitutive NOS activity.

Download full-text PDF

Source
http://dx.doi.org/10.1139/y11-027DOI Listing

Publication Analysis

Top Keywords

protective l-citrulline
8
gastric mucosal
8
induced ischemia-reperfusion
8
ischemia-reperfusion rats
8
300 600
8
600 900
8
900 mg/kg
8
activity inducible
8
constitutive activity
8
gastric mucus
8

Similar Publications

The prevalence of cardiovascular-kidney-metabolic (CKM) syndrome is increasing rapidly, and cardiovascular complications pose significant risks in individuals with kidney disease and metabolic dysfunction. Understanding the mechanisms of CKM disorders is crucial, as is the discovery of novel preventive treatments. This study aimed to examine the therapeutic effects of a specially formulated nitric oxide-enhancing food additive in a mouse model of CKM syndrome induced by unilateral nephrectomy (UNX) in combination with chronic Western diet (WD) feeding.

View Article and Find Full Text PDF
Article Synopsis
  • L-citrulline, a non-essential amino acid involved in the urea cycle, is primarily known for its role in managing genetic urea cycle disorders, but recent studies reveal its potential in treating conditions linked to nitric oxide deficiency and oxidative stress.
  • Citrulline may have beneficial effects in several medical conditions such as sickle cell disease, post-operative pulmonary hypertension, hepatic veno-occlusive disease, and bronchopulmonary dysplasia, by enhancing nitric oxide production and improving vascular health.
  • While promising results suggest citrulline could serve as an adjunct therapy in these conditions, more research is needed to establish proper dosing and long-term safety and effectiveness.
View Article and Find Full Text PDF
Article Synopsis
  • Chemotherapy and radiation can damage the gastrointestinal (GI) barrier, leading to serious side effects like fatigue, malnutrition, and sometimes death.
  • Apraglutide, a GLP-2 analog, was tested in mice and found to improve survival rates and reduce weight loss after treatment with chemotherapy and during allogeneic transplantation.
  • The study showed that apraglutide helps maintain GI health by preserving the structure of the GI mucosa and improving intestinal microbiota compared to those receiving chemotherapy alone.
View Article and Find Full Text PDF

Background: There is growing interest in the use of nutrition and dietary supplements to optimize training and time-trial (TT) performance in cyclists. Separately, quercetin (QCT) and citrulline (CIT) have been used as ergogenic aids to improve oxygen (VO) kinetics, perceived effort, and cycling TT performance. However, whether the combination of QCT and CIT can provide additive benefits and further enhance cycling performance production is currently unknown.

View Article and Find Full Text PDF

Effects of supplementing rumen-protected arginine on performance of transition cows.

J Dairy Sci

December 2024

Department of Animal Sciences, University of Florida, Gainesville FL 32611; DH Barron Reproductive and Perinatal Biology Research Program, University of Florida, Gainesville, FL 32611. Electronic address:

An experiment was conducted to determine the effects of supplementing rumen-protected arginine (RPA) on productive performance in dairy cows. One-hundred and two cows were blocked by parity and then by ECM yield. Within block, cows were randomly assigned to control (CON) that received 200 g/d of a mixture of hydrogenated soybean oil and heat-treated soybean meal to supply 30 g of MP, or 200 g/d of a product containing 30 g of metabolizable arginine (RPA), which increased the dietary arginine from 5.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!